Effects of CNQX and MPEP on sensitization to the rewarding effects of morphine

European Journal of Pharmacology

Volumn 654, Issue 1, 2011, Pages 42-46

  Manzanedo, Carmen ^a   Aguilar, María A ^a   Miñarro, José ^a   Rodríguez Arias, Marta ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

Author keywords

AMPA amino 3 hydroxy 5 methyl 4 isoxazolepropionic acid receptor; CNQX 6 cyano 7 nitroquinoxaline 2,3 dione ; Conditioned place preference; mGlu5 metabotropic glutamate 5 receptor; Morphine; MPEP 6 methyl 2 (phenylethynyl) pyridine ; Reward; Sensitization

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; METABOTROPIC RECEPTOR 5; MORPHINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; ANIMALS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MICE; MORPHINE; PYRIDINES; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; REWARD;

EID: 78951490491     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.11.037     Document Type: Article

References (51)

1. M.A. Aguilar, C. Manzanedo, B.R. Do Couto, M. Rodríguez-Arias, and J. Miñarro Memantine blocks sensitization to the rewarding effects of morphine Brain Res. 1288 2009 95 104
2. A. Atalla, and K. Kuschinsky Effects of blockade of glutamate NMDA receptors or of NO synthase on the development or the expression of associative or non-associative sensitization to locomotor activation by morphine J. Neural Transm. 113 2006 1 10
3. W.A. Carlezon Jr., K. Rasmussen, and E.J. Nestler AMPA antagonist LY293558 blocks the development, without blocking the expression, of behavioral sensitization to morphine Synapse 31 1999 256 262
4. W.A. Carlezon, V.A. Boundy, C.N. Haile, S.B. Lane, R.G. Kalb, R.L. Neve, and E.J. Nestler Sensitization to morphine induced by viral-mediated gene transfer Science 277 1997 812 814
5. W.A. Carlezon, T.A. Kosten, and E.J. Nestler Behavioral interactions caused by combined administration of morphine and MK-801 in rats Psychopharmacology 151 2000 261 272
6. J.E. Dallimore, A.L. Mickiewicz, and T.C. Napier Intra-ventral pallidal glutamate antagonists block expression of morphine-induced place preference Behav. Neurosci. 120 2006 1103 1114
7. F. Gasparini, K. Lingenhöhl, N. Stoehr, P.J. Flor, M. Heinrich, I. Vranesic, M. Biollaz, H. Allgeier, R. Heckendorn, S. Urwyler, M.A. Varney, E.C. Johnson, S.D. Hess, S.P. Rao, A.I. Sacaan, E.M. Santori, G. Veliçelebi, and R. Kuhn 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist Neuropharmacology 38 1999 1493 1503
8. G.C. Harris, M. Wimmer, R. Byrne, and G. Aston-Jones Glutamate-associated plasticity in the ventral tegmental area is necessary for conditioning environmental stimuli with morphine Neuroscience 129 2004 841 847
9. V. Herzig, E.M. Capuani, K.A. Kovar, and W.J. Schmidt Effects of MPEP on expression of food-, MDMA- or amphetamine-conditioned place preference in rats Addict. Biol. 10 2005 243 249
10. V. Herzig, and W.J. Schmidt Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine Neuropharmacology 47 2004 973 984
11. M. Hollmann, and S. Heinemann Cloned glutamate receptors Annu. Rev. Neurosci. 17 1994 31 108
12. Y. Iijima, T. Asami, and H. Kuribara Modification by MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist, of morphine sensitization: evaluation by ambulation in mice Nihon Shinkei Seishin Yakurigaku Zasshi 16 1996 11 18
13. M. Jeziorski, F.J. White, and M.E. Wolf MK-801 prevents the development of behavioral sensitization during repeated morphine administration Synapse 16 1994 137 147
14. P.W. Kalivas, and C. O'Brien Drug addiction as a pathology of staged neuroplasticity Neuropsychopharmacology 33 2008 166 180
15. P.W. Kalivas, N. Volkow, and J. Seamans Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission Neuron 45 2005 647 650
16. J. Kotlinska, and M. Bochenski Comparison of the effects of mGluR1 and mGlu5 antagonists on the expression of behavioral sensitization to the locomotor effect of morphine and the morphine withdrawal jumping in mice Eur. J. Pharmacol. 558 2007 113 118
17. D.A. Lane, A.A. Lessard, J. Chan, E.E. Colago, Y. Zhou, S.D. Schlussman, M.J. Kreek, and V.M. Pickel Region-specific changes in the subcellular distribution of AMPA receptor GluR1 subunit in the rat ventral tegmental area after acute or chronic morphine administration J. Neurosci. 28 2008 9670 9681
18. R.T. Layer, N.J. Uretsky, and L.J. Wallace Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference Brain Res. 617 1993 267 273
19. P.M. Lea, and A.I. Faden Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP.CNS Drug Rev. Summer 12 2006 149 166
20. J. Le Merrer, and D.N. Stephens Food-induced behavioral sensitization, its cross-sensitization to cocaine and morphine, pharmacological blockade, and effect on food intake J. Neurosci. 26 2006 7163 7171
21. B.T. Lett Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine Psychopharmacology 98 1989 357 362
22. C. Manzanedo, M.A. Aguilar, B.R. Do Couto, M. Rodríguez-Arias, and J. Miñarro Involvement of nitric oxide synthesis in sensitization to the rewarding effects of morphine Neurosci. Lett. 464 2009 67 70
23. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Effects of dopamine with different blockade profiles on morphine-induced place preference in male mice Behav. Brain Res. 121 2001 189 197
24. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, and J. Miñarro Sensitization to the rewarding effects of morphine depends on dopamine NeuroReport 16 2005 201 205
25. C. Manzanedo, M.A. Aguilar, M. Rodríguez-Arias, M. Navarro, and J. Miñarro Cannabinoid agonist-induced sensitisation to morphine place preference in mice NeuroReport 15 2004 1373 1377
26. A.J. McGeehan, and M.F. Olive The mGlu5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse Synapse 47 2003 240 242
27. I.A. Mendez, and K.A. Trujillo NMDA receptor antagonists inhibit opiate antinociceptive tolerance and locomotor sensitization in rats Psychopharmacology 196 2008 497 509
28. R.L. Neve, J.R. Howe, S. Hong, and R.G. Kalb Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus Neuroscience 79 1997 435 447
29. M.F. Olive, A.J. McGeehan, J.R. Kinder, T. McMahon, C.W. Hodge, P.H. Janak, and R.O. Messing The mGlu5 antagonist 6-methyl-2-(phenylethynyl)pyridine decreases ethanol consumption via a protein kinase C epsilon-dependent mechanism Mol. Pharmacol. 67 2005 349 355
30. P. Popik, and M. Wrobel Morphine conditioned reward is inhibited by MPEP, the mGlu5 antagonist Neuropharmacology 43 2002 1210 1217
31. R. Ranaldi, E. Munn, T. Neklesa, and R.A. Wise Morphine and amphetamine sensitization in rats demonstrated under moderate- and high-dose NMDA receptor blockade with MK-801 (dizocilpine) Psychopharmacology 151 2000 192 201
32. K. Rasmussen, H. Martin, J.E. Berger, and M.A. Seager The mGlu5 receptor antagonists MPEP and MTEP attenuate behavioral signs of morphine withdrawal and morphine-withdrawal-induced activation of locus coeruleus neurons in rats Neuropharmacology 48 2008 173 180
33. T.E. Robinson, and K.C. Berridge The neural basis of drug craving: an incentive-sensitization theory of addiction Brain Res. Rev. 18 1993 247 291
34. T.E. Robinson, and K.C. Berridge Addiction Annu. Rev. Psychol. 54 2003 25 53
35. K. Rutten, E.L. van der Kam, J. De Vry, W. Bruckmann, and T.M. Tzschentke The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats Addict. Biol. 16 2011 108 115
36. Z. Sepehrizadeh, M. Bahrololoumi Shapourabadi, S. Ahmadi, S. Hashemi Bozchlou, M.R. Zarrindast, and M. Sahebgharani Decreased AMPA GluR2, but not GluR3, mRNA expression in rat amygdala and dorsal hippocampus following morphine-induced behavioural sensitization Clin. Exp. Pharmacol. Physiol. 35 2008 1321 1330
37. M. Shabat-Simon, D. Levy, A. Amir, M. Rehavi, and A. Zangen Dissociation between rewarding and psychomotor effects of opiates: differential roles for glutamate receptors within anterior and posterior portions of the ventral tegmental area J. Neurosci. 28 2008 8406 8416
38. T.S. Shippenberg, V.I. Chefer, and A.C. Thompson Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine Biol. Psychiatry 65 2009 169 174
39. T.S. Shippenberg, C. Heidbreder, and A. LeFevour Sensitization to the conditioned rewarding effects of morphine: pharmacology and temporal characteristics Eur. J. Pharmacol. 299 1996 33 39
40. T.S. Shippenberg, A. LeFevour, and A.C. Thompson Sensitization to the conditioned rewarding effects of morphine and cocaine: differential effects of the κ-opioid receptor agonist U69593 Eur. J. Pharmacol. 345 1998 27 34
41. V. Tronci, S. Vronskaya, N. Montgomery, D. Mura, and D.J. Balfour The effects of the mGlu5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine Psychopharmacology 211 2010 33 42
42. T.M. Tzschentke, and W.J. Schmidt Procedural examination of behavioural sensitisation to morphine: lack of blockade by MK-801, occurrence of sensitised sniffing, and evidence for cross-sensitisation between morphine and MK-801 Behav. Pharmacol. 7 1996 169 184
43. T.M. Tzschentke, and W.J. Schmidt Does the noncompetitive NMDA receptor antagonist dizocilpine (MK801) really block behavioural sensitization associated with repeated drug administration? Trends Pharmacol. Sci. 19 1998 447 451
44. T.M. Tzschentke, and W.J. Schmidt Blockade of morphine- and amphetamine-induced conditioned place preference in the rat by riluzole Neurosci. Lett. 242 1998 114 116
45. T.M. Tzschentke, and W.J. Schmidt Glutamatergic mechanisms in addiction Mol. Psychiatry 8 2003 373 382
46. T.M. Tzschentke, and W.J. Schmidt Blockade of behavioral sensitization by MK-801: fact or artifact? A review of preclinical data Psychopharmacology 151 2000 142 151
47. E.L. van der Kam, J. de Vry, and T.M. Tzschentke Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat Behav. Pharmacol. 18 2007 717 724
48. E.L. van der Kam, J. De Vry, and T.M. Tzschentke The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat Eur. J. Pharmacol. 607 2009 114 120
49. E.L. van der Kam, J. De Vry, and T.M. Tzschentke 2-Methyl-6- (phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat Eur. J. Pharmacol. 606 2009 94 101
50. L.J. Vanderschuren, A.N. Schoffelmeer, and T.J. De Vries Does dizocilpine (MK-801) inhibit the development of morphine-induced behavioural sensitization in rats? Life Sci. 61 1997 PL427 PL433
51. M.R. Zarrindast, M. Ebrahimi-Ghiri, P. Rostami, and A. Rezayof Repeated pre-exposure to morphine into the ventral pallidum enhances morphine-induced place preference: involvement of dopaminergic and opioidergic mechanisms Behav. Brain Res. 181 2007 35 41